Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 USD | -7.23% | -17.65% | -86.00% |
Apr. 02 | CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 11 | Top Premarket Decliners | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 68.71M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | -2M | EV / Sales 2022 | - |
Net Debt 2022 | 174K | Net Debt 2023 | 1.46M | EV / Sales 2023 | - |
P/E ratio 2022 |
-346
x | P/E ratio 2023 |
-28.3
x | Employees | 9 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.78% |
1 day | -7.23% | ||
1 week | -17.65% | ||
Current month | -49.84% | ||
1 month | -26.67% | ||
3 months | -86.12% | ||
6 months | -85.86% | ||
Current year | -86.00% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.29% | 15 M€ | -0.60% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 1.54 | -7.23% | 129,984 |
24-04-17 | 1.66 | -8.29% | 60,856 |
24-04-16 | 1.81 | +3.43% | 79,587 |
24-04-15 | 1.75 | -1.69% | 107,877 |
24-04-12 | 1.78 | -4.81% | 107,530 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-86.00% | 22.67M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-0.82% | 21.66B | |
-18.35% | 20.77B | |
-7.68% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- CERO Stock